What happens at the end of my 14-day free trial?
If you'd like to activate your account, simply add your credit card and billing information to your account at the end of the trial. If, not your account automatically becomes inactive. For more information on how to activate your account, please click here.
When (and how) will I be charged for my subscription?
Your billing cycle will begin on the day your trial expires. You will be automatically charged each month (or each year, if you've selected an annual subscription), using the card information on file for your account.
What's the cost of having multiple users?
Bill4Time is a subscription-based service, which is priced per-user. Your overall monthly/yearly cost will be calculated at the time of billing, based on the number of users you currently have active in your system.
Where can I view pricing info?
To view your current pricing, click your name at the top right of any page and select "Subscription" in the dropdown menu. From there, you can view your current plan and the per-user pricing associated with that plan.
What happens if I add a user in the middle of my billing cycle?
When adding a user in the middle of a monthly billing cycle, you will be billed a full month for that user and it will appear as an adjustment on your next bill. When adding a user in the middle of an annual billing cycle, you will be instantly charged a pro-rated amount, based on the number of remaining months left in your annual billing cycle.
Are there additional fees for the monthly subscription?
No. This subscription includes unlimited technical support, software updates, backups, and mobile/tablet/widget applications. There are no hidden charges.
Do you provide a volume discount for large companies?
Yes. We do offer volume pricing/discounts for larger companies/departments. Please contact firstname.lastname@example.org for more information regarding this.
What is the refund policy?
Please refer to our official Refund Policy, located here: http://www.bill4time.com/refund-policy/
Article is closed for comments.